Cardiotoxicity From Human Epidermal Growth Factor Receptor-2 (HER2) Targeted Therapies.
Publication
, Journal Article
Florido, R; Smith, KL; Cuomo, KK; Russell, SD
Published in: J Am Heart Assoc
September 22, 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Am Heart Assoc
DOI
EISSN
2047-9980
Publication Date
September 22, 2017
Volume
6
Issue
9
Location
England
Related Subject Headings
- Signal Transduction
- Risk Factors
- Risk Assessment
- Receptor, erbB-2
- Receptor, ErbB-2
- Protein Kinase Inhibitors
- Myocardium
- Molecular Targeted Therapy
- Humans
- Heart Diseases
Citation
APA
Chicago
ICMJE
MLA
NLM
Florido, R., Smith, K. L., Cuomo, K. K., & Russell, S. D. (2017). Cardiotoxicity From Human Epidermal Growth Factor Receptor-2 (HER2) Targeted Therapies. J Am Heart Assoc, 6(9). https://doi.org/10.1161/JAHA.117.006915
Florido, Roberta, Karen L. Smith, Kimberly K. Cuomo, and Stuart D. Russell. “Cardiotoxicity From Human Epidermal Growth Factor Receptor-2 (HER2) Targeted Therapies.” J Am Heart Assoc 6, no. 9 (September 22, 2017). https://doi.org/10.1161/JAHA.117.006915.
Florido R, Smith KL, Cuomo KK, Russell SD. Cardiotoxicity From Human Epidermal Growth Factor Receptor-2 (HER2) Targeted Therapies. J Am Heart Assoc. 2017 Sep 22;6(9).
Florido, Roberta, et al. “Cardiotoxicity From Human Epidermal Growth Factor Receptor-2 (HER2) Targeted Therapies.” J Am Heart Assoc, vol. 6, no. 9, Sept. 2017. Pubmed, doi:10.1161/JAHA.117.006915.
Florido R, Smith KL, Cuomo KK, Russell SD. Cardiotoxicity From Human Epidermal Growth Factor Receptor-2 (HER2) Targeted Therapies. J Am Heart Assoc. 2017 Sep 22;6(9).
Published In
J Am Heart Assoc
DOI
EISSN
2047-9980
Publication Date
September 22, 2017
Volume
6
Issue
9
Location
England
Related Subject Headings
- Signal Transduction
- Risk Factors
- Risk Assessment
- Receptor, erbB-2
- Receptor, ErbB-2
- Protein Kinase Inhibitors
- Myocardium
- Molecular Targeted Therapy
- Humans
- Heart Diseases